Induction of labour with vaginal misoprostol, in women with premature rupture of membranes at term, results in significant shortening of induction to delivery time in comparison to vaginal PGE2 gel induction...
Date First Received: July 18, 2006
Last Updated: November 10, 2008
Verified by: Nilratan Sircar Medical College, November 2008
Clinical Trial Phase: Phase 4 | Start Date: August 2006
Overall Status: Completed
Estimated Enrollment: 212
Brief Summary
Official Title: “Comparison of Misorostol & PGE2 Gel for Immediate Induction of Labour for Premature Ropture of Membranes at Term”
Condition Keyword(s):
Intervention(s):
Induction of labour with vaginal misoprostol, in women with premature rupture of membranes at term, results in significant shortening of induction to delivery time in comparison to vaginal PGE2 gel induction.
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Study Primary Completion Date: September 2008
Intervention(s) in this Clinical Trial
- Drug: Misoprostol
- In one group of women immediate induction of labour will be done by intravaginal misoprostol 25 microgram 4 hourly , a maximum of 5 doses .
- Drug: PGE2 gel
- In other group immediate induction of labour will be done by intravaginal application of PGE2 gel 0.5 mg at an interval of 6 hours , a maximum of 2 doses.
Arms, Groups and Cohorts in this Clinical Trial
- Active Comparator: A
- In group A, immediate induction of labour will be done by intravaginal misoprostol 25 microgram 4 hourly , a maximum of 5 doses .
- Active Comparator: B
- In Group B immediate induction of labour will be done by application of vaginal PGE2 gel 0.5 gm at an interval of 6 hours , a maximum of 2 doses.
Outcome Measures for this Clinical Trial
Primary Measures
- Admission to delivery time
- Time Frame: 48 hours
Safety Issue?: Yes
- Time Frame: 48 hours
Secondary Measures
- Caesarean Section rate
- Time Frame: 48 hours
Safety Issue?: No
- Time Frame: 48 hours
- Neonatal morbidity
- Time Frame: Till discharge
Safety Issue?: Yes
- Time Frame: Till discharge
- Maternal morbidity
- Time Frame: Till discharge
Safety Issue?: Yes
- Time Frame: Till discharge
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Premature rupture of membranes at 37 or more weeks
- Single live fetus in cephalic presentation
Exclusion Criteria:
- Women in labour
- Women with contraindication of induction of labour
- Women with previous caesarean section or uterine surgery
Gender Eligibility for this Clinical Trial: Female
Minimum Age for this Clinical Trial: N/A
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Nilratan Sircar Medical College
Overall Clinical Trial Officials and Contacts
Snehamay Chaudhuri, MBBS,MD,DNB Principal Investigator NRS Medical College , Kolkata, India
Additional Information
Information obtained from ClinicalTrials.gov on July 02, 2009
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00355966
Study ID Number: 1-Chaudhuri
ClinicalTrials.gov Identifier: NCT00355966
Health Authority: India: Ministry of Health
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.